Retour
Poniard Pharmaceuticals Inc (PARD) Gagner
Graphique du cours de l'action PARD
PARD Gagner
Poniard Pharmaceuticals Inc
$0
0%
$0
À la fermeture : Mar 23, 16:00:00 GMT-4
$0
0%
$0
Post-Marché: Mar 23, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$0.0001
Prix d'ouverture
$0.0001
Plage de la journée
$0.0001 - $0.0001
Plage de 52 semaines
$0.0001 - $0.0001
Volume
7
Volume moyen
0
Rendement en dividend
--
BPA (TTM)
-11.78
Capitalisation boursière
$150
Qu’est-ce que PARD ?
Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
